Collagenase and Tissue Inhibitor Expression in Pancreatic Cancer
Author Information
Author(s): SR Bramhall, GWH Stamp, J Dunn, NR Lemoine, JP Neoptolemos
Primary Institution: City Hospital NHS Trust Birmingham; ICRF Oncology Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London; University of Birmingham; Queen Elizabeth Hospital, Birmingham, UK.
Hypothesis
The study investigates the expression of metalloproteinases and their inhibitors in pancreatic and ampullary cancers.
Conclusion
The study found that MMP2, MMP3, and TIMP1 are significantly expressed in pancreatic and ampullary cancers, suggesting their role in tumor invasion and metastasis.
Supporting Evidence
- The abundance of MMP2, MMP3, and TIMP1 was greater in pancreatic and ampullary cancer than in other pathologies.
- Immunoreactivity in malignant epithelial cells was significantly higher than in stromal tissues.
- Strong correlations were found between the immunoreactivity of MMP2 and TIMP1.
Takeaway
This study looked at how certain proteins related to cancer are found in patients with pancreatic and ampullary cancers, showing that these proteins might help the cancer spread.
Methodology
Immunohistochemistry was performed on tissue sections from 50 patients to assess the expression of MMP2, MMP3, and TIMP1.
Participant Demographics
Patients included 27 with pancreatic cancer, 12 with ampullary cancer, 3 with low bile duct cancer, 3 with neuroendocrine tumors, and 5 with chronic pancreatitis.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website